Global Genes® RARE Patient Impact Grant Program is an exclusive funding opportunity for rare-disease patient support groups and RARE Foundation Alliance partner organizations. (The RARE Foundation Alliance is a coalition of over 300 rare disease organizations that exchange best practices and share lessons learned to achieve better outcomes for the entire rare disease community.)
The first step in the application process is the submission of a Letter of Intent. Your Letter of Intent will be evaluated based on same selection criteria as the full grant application:
1) Innovative 2) Impactful 3) Achievable 4) Tangible and 5) Scalable. The Letter of Intent Deadline is Friday, August 11, 2017 at 11:59 p.m. Pacific Time. The Full Application is due (from those having accepted Letters of Intent only) by Monday, September 18, 2017 at 11:59 p.m. Pacific Time. RARE Patient Impact Grant applicant presentations will occur during the week of December 4, 2017. A handy online contact form will facilitate your questions reaching the correct person at Global Genes®.